Drug Type Unknown |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization STAT3 Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization STAT3 Therapeutics, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | US | STAT3 Therapeutics, Inc.Startup | 27 Nov 2021 |